Shanghai Pharmaceuticals Holding Co Ltd (601607) — Cash Flow-to-Debt Ratio
Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥1.56 Billion could theoretically repay 0% of its total liabilities (CN¥147.12 Billion) in one year. See 601607 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Pharmaceuticals Holding Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Shanghai Pharmaceuticals Holding Co Ltd across 28 annual periods. Also explore 601607 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Shanghai Pharmaceuticals Holding Co Ltd. For market capitalisation and broader financial context, see Shanghai Pharmaceuticals Holding Co Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | CN¥6.15 Billion | CN¥143.36 Billion | ▲ +1.3% |
| 2024 | 0.04x | CN¥5.83 Billion | CN¥137.47 Billion | ▲ +6.7% |
| 2023 | 0.04x | CN¥5.23 Billion | CN¥131.65 Billion | ▲ +0.6% |
| 2022 | 0.04x | CN¥4.74 Billion | CN¥120.13 Billion | ▼ -18.6% |
| 2021 | 0.05x | CN¥5.06 Billion | CN¥104.37 Billion | ▼ -33.1% |
| 2020 | 0.07x | CN¥6.84 Billion | CN¥94.44 Billion | ▲ +5.5% |
| 2019 | 0.07x | CN¥6.02 Billion | CN¥87.64 Billion | ▲ +76.3% |
| 2018 | 0.04x | CN¥3.14 Billion | CN¥80.45 Billion | ▼ -19.6% |
| 2017 | 0.05x | CN¥2.65 Billion | CN¥54.67 Billion | ▲ +14.3% |
| 2016 | 0.04x | CN¥1.95 Billion | CN¥45.91 Billion | ▲ +27.4% |
| 2015 | 0.03x | CN¥1.35 Billion | CN¥40.54 Billion | ▼ -17.2% |
| 2014 | 0.04x | CN¥1.34 Billion | CN¥33.24 Billion | ▲ +12.7% |
| 2013 | 0.04x | CN¥973.45 Million | CN¥27.31 Billion | ▼ -27.6% |
| 2012 | 0.05x | CN¥1.15 Billion | CN¥23.37 Billion | ▼ -39.7% |
| 2011 | 0.08x | CN¥1.77 Billion | CN¥21.69 Billion | ▼ -21.1% |
| 2010 | 0.10x | CN¥1.69 Billion | CN¥16.28 Billion | ▼ -1.2% |
| 2009 | 0.10x | CN¥664.13 Million | CN¥6.33 Billion | ▲ +107.9% |
| 2008 | 0.05x | CN¥285.68 Million | CN¥5.67 Billion | ▼ -46.7% |
| 2007 | 0.09x | CN¥488.94 Million | CN¥5.17 Billion | ▼ -25.2% |
| 2006 | 0.13x | CN¥583.11 Million | CN¥4.61 Billion | ▲ +656.9% |
| 2005 | 0.02x | CN¥73.00 Million | CN¥4.37 Billion | ▲ +19.3% |
| 2004 | 0.01x | CN¥61.66 Million | CN¥4.40 Billion | ▲ +11546.7% |
| 2003 | 0.00x | CN¥484.27K | CN¥4.03 Billion | ▼ -99.6% |
| 2002 | 0.03x | CN¥100.84 Million | CN¥3.40 Billion | ▲ +11.6% |
| 2001 | 0.03x | CN¥65.73 Million | CN¥2.47 Billion | ▼ -53.7% |
| 2000 | 0.06x | CN¥146.22 Million | CN¥2.55 Billion | ▼ -23.2% |
| 1999 | 0.07x | CN¥164.67 Million | CN¥2.21 Billion | ▲ +150.0% |
| 1998 | -0.15x | CN¥-283.14 Million | CN¥1.90 Billion | — |